BIOMAT Database Logo BIOMAT Database Logo

[Technic of analysis and variations in plasma level of o,p'-DDD]. 1978

A Enger, and J M Brunetaud, and Y Moschetto

UI MeSH Term Description Entries
D008939 Mitotane A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression. o,p-DDD,ortho,para-DDD,Chloditan,Chlodithane,Khloditan,Lysodren,Mytotan,ortho,para DDD
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Enger, and J M Brunetaud, and Y Moschetto
[Plasma determination of O,P-DDD. Clinical value].
February 1977, La Nouvelle presse medicale,
A Enger, and J M Brunetaud, and Y Moschetto
Mitotane (o,p'-DDD).
March 1980, Cancer treatment reviews,
A Enger, and J M Brunetaud, and Y Moschetto
Estimation of o,p'-DDD in plasma by gas-liquid chromatography.
April 1977, Clinica chimica acta; international journal of clinical chemistry,
A Enger, and J M Brunetaud, and Y Moschetto
o,p'--DDD and adrenal carcinoma.
December 1978, Irish journal of medical science,
A Enger, and J M Brunetaud, and Y Moschetto
Plasma level monitoring of mitotane (o,p'-DDD) and its metabolite (o,p'-DDE) during long-term treatment of Cushing's disease with low doses.
January 1991, European journal of clinical pharmacology,
A Enger, and J M Brunetaud, and Y Moschetto
Determination of mitotane (o,p-DDD) and its metabolites o,p-DDA and o,p-DDE in plasma by high-performance liquid chromatography.
June 1999, Therapeutic drug monitoring,
A Enger, and J M Brunetaud, and Y Moschetto
Use of GC/MS/SIM for rapid determination of plasma levels of o,p'-DDD, o,p'-DDE and o,p'-DDA.
December 1987, Clinica chimica acta; international journal of clinical chemistry,
A Enger, and J M Brunetaud, and Y Moschetto
Effect of o,p'-DDD on plasma ACTH concentration in Cushing's disease.
January 1979, Medicina,
A Enger, and J M Brunetaud, and Y Moschetto
Cardiovascular effects of o,p'-DDD.
July 1968, IMS, Industrial medicine and surgery,
A Enger, and J M Brunetaud, and Y Moschetto
The effect of o,p'-DDD therapy on plasma cholesterol in adrenal carcinoma.
November 1961, Proceedings of the staff meetings. Mayo Clinic,
Copied contents to your clipboard!